New York Life Investment Management’s Aecom ACM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Sell
15,931
-341
-2% -$26.1K 0.01% 671
2026
Q1
$1.38M Buy
16,272
+4,123
+34% +$391K 0.01% 609
2025
Q4
$1.16M Sell
12,149
-1,643
-12% -$193K 0.01% 584
2025
Q3
$1.8M Sell
13,792
-486
-3% -$58.7K 0.02% 563
2025
Q2
$1.61M Sell
14,278
-302
-2% -$31.4K 0.02% 569
2025
Q1
$1.35M Sell
14,580
-284
-2% -$28.8K 0.01% 609
2024
Q4
$1.59M Sell
14,864
-1,667
-10% -$182K 0.02% 586
2024
Q3
$1.71M Sell
16,531
-15
-0.1% -$1.41K 0.02% 603
2024
Q2
$1.46M Buy
16,546
+2,137
+15% +$195K 0.01% 619
2024
Q1
$1.41M Sell
14,409
-948
-6% -$85.7K 0.01% 611
2023
Q4
$1.42M Sell
15,357
-155
-1% -$13.2K 0.01% 597
2023
Q3
$1.29M Buy
15,512
+7,829
+102% +$675K 0.01% 587
2023
Q2
$651K Buy
+7,683
New +$630K 0.01% 631

Other funds holding ACM

New York Life Investment Management's ACM Position: Q2 2026 in Review

New York Life Investment Management reduced its Aecom (ACM) stake by 2.1% in Q2 2026, selling an estimated $26.1K and leaving 15,931 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #671.

New York Life Investment Management first reported a position in ACM in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.8M in Q3 2025. 409 funds tracked by Wall St. Rank hold ACM as of Q2 2026.

  • New York Life Investment Management held 15,931 shares of Aecom worth $1.11M as of Q2 2026.
  • New York Life Investment Management sold 341 Aecom shares in Q2 2026, an estimated $26.1K.
  • Aecom made up 0.01% of New York Life Investment Management's portfolio in Q2 2026, its #671 holding.
  • New York Life Investment Management first reported a position in Aecom in Q2 2023 and has held it in 13 quarters since.
  • New York Life Investment Management's Aecom position peaked at $1.8M in Q3 2025.
  • 409 funds tracked by Wall St. Rank held Aecom as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.